Aug. 12, 2013News & Opinions
China has started investigating French drugmaker Sanofi for allegedly bribing more than 500 Chinese doctors with about 1.7 million yuan ($277,600) of payments to raise sales, China's Xinhua state news agency reported.
Aug. 09, 2013News & Opinions
Chinese authorities have visited a site operated by Danish drug maker Novo Nordisk, the world's biggest maker of insulin, in the latest sign of a widening investigation into Western drugmakers.
GlaxoSmithKline raised its bet on using electrical signals in the body to target diseases on Thursday with the launch of a $50 million strategic venture capital fund.
Aug. 07, 2013News & Opinions
Times are getting tough for European firms in emerging markets where HSBC talks of a cyclical "slowdown", Diageo sees "choppy conditions" and Unilever views deceleration as the "new normal."
Aug. 05, 2013News & Opinions
India has revoked a patent granted to GlaxoSmithKline for breast cancer drug Tykerb, a decision that follows a landmark India court ruling disallowing patents for incremental innovations that was a blow to global pharmaceutical firms.
Aug. 02, 2013News & Opinions
Chinese authorities visited a regional office of French drugmaker Sanofi this week in the latest sign of a widening investigation into Western drugmakers.
British drugmaker AstraZeneca warned on Thursday of higher costs in 2013 as it invests through a slump in sales caused by a wave of patent expiries on key medicines.
Jul. 30, 2013News & Opinions
Expectations that Bayer will embrace a trend in the pharma sector to split off non-core units may be too far ahead of the curve.
Jul. 29, 2013News & Opinions
China has a drug problem. While most Western countries spend 10-12% of their healthcare budget on medicines, in China it is well over 40%, a disparity that goes to the heart of Beijing's crackdown on the industry.
Swiss drugmaker Novartis won an important endorsement of its new inhaled medicine for chronic lung disease on Friday when European regulators recommended approval of Ultibro Breezhaler.
The latest information directly via newsletter.